Targeting of Cdc42 GTPase in regulatory T cells unleashes anti-tumor T cell immunity is a research paper published in bioRxiv (Cold Spring Harbor Laboratory) (2021). On theSindex it has a DataRank of 0.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R56HL141499-01
RhoA in T Cell-mediated Airway Inflammation
National Institutes of Health
Grant: 1R01CA234038-01A1
The role of transcription elongation defects in immunotherapy resistance in cancers
National Institutes of Health
Grant: 5R01GM108661-04
Novel Signaling Function of Cdc42 GTPase in vivo
National Institutes of Health
Grant: 5R50CA211404-04
Therapeutic insights through patient derived leukemia xenografts
Fields of Study
Keywords
Sustainable Development Goals